Hyderabad: City-based Bharat Biotech on Monday announced that its Covid-19 intranasal vaccine iNCOVACC (BBV154) has received approval from the Central Drugs Standard Control Organisation (CDSCO) for restricted use in emergency situation for ages 18 and above in India for heterologous booster doses. ...